acenocoumarol (Q304088)

ACENOCOUMAROL (English)

19 November 2016

canonical SMILES

CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(C3=CC=CC=C3OC2=O)O

1 reference

ACENOCOUMAROL (English)

https://www.whocc.no/atc_ddd_index/?code=B01AA07

19 November 2016

defined daily dose

5 milligram

route of administration

oral administration

1 reference

reference URL

World Health Organisation international non-proprietary name

acenocoumarol (English)

2 references

acenocoumarol (English)

significant drug interaction

3 October 2016

published in

Recommended INN: List 3

publication date

1959

enoxaparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dalteparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tinzaparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rac-warfarin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

urokinase

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alteplase

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenecteplase

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Streptokinase

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rivaroxaban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

apixaban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(±)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ticagrelor

1 reference

A reference set of clinically relevant adverse drug-drug interactions

vortioxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibrutinib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

abciximab

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sertraline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

venlafaxine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluvoxamine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(S)-duloxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amiodarone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

capecitabine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulfamethoxazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-tegafur

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluorouracil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tamoxifen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

voriconazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluconazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rac-miconazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paracetamol

increased blood clotting time

1 reference

A reference set of clinically relevant adverse drug-drug interactions

phenobarbital

short coagulation time

1 reference

A reference set of clinically relevant adverse drug-drug interactions

methylprednisolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dexamethasone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prednisolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prednisone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

triamcinolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

betamethasone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fenofibrate

increased blood clotting time

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bezafibrate

increased blood clotting time

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rosuvastatin

increased international normalised ratio

1 reference

A reference set of clinically relevant adverse drug-drug interactions

levofloxacin hemihydrate

increased international normalised ratio

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clarithromycin

increased international normalised ratio

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clarithromycin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clarithromycin

increased prothrombin time ratio

1 reference

A reference set of clinically relevant adverse drug-drug interactions

mass

353.089937 dalton

1 reference

InChI=1S/C19H15NO6/c1-11(21)10-15(12-6-8-13(9-7-12)20(24)25)17-18(22)14-4-2-3-5-16(14)26-19(17)23/h2-9,15,22H,10H2,1H3

ACENOCOUMAROL (English)

3 October 2016

1 reference

Medical Subject Headings

15 March 2018

Acenocoumarol

0 references

Identifiers

InChI

1 reference

ACENOCOUMAROL (English)

19 November 2016

2 references

ACENOCOUMAROL (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

152-72-7

2 references

acenocoumarol (English)

19 November 2016

https://commonchemistry.cas.org/detail?cas_rn=152-72-7

9 April 2021

1 reference

acenocoumarol (English)

19 November 2016

2 references

ACENOCOUMAROL (English)

19 November 2016

Reaxys registry number

1269370

1 reference

acenocoumarol (English)

3 October 2016

ChEBI ID

53766

mapping relation type

2 references

ACENOCOUMAROL (English)

19 November 2016

International Chemical Identifier

InChI

InChI=1S/C19H15NO6/c1-11(21)10-15(12-6-8-13(9-7-12)20(24)25)17-18(22)14-4-2-3-5-16(14)26-19(17)23/h2-9,15,22H,10H2,1H3

1 reference

ACENOCOUMAROL (English)

19 November 2016

2 references

inferred from InChIKey

Hazardous Substances Data Bank

1 reference

1 reference

28 October 2019

ACENOCOUMAROL (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

1 reference

acenocoumarol (English)

ECHA Substance Infocard ID

19 November 2016

100.005.281

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.005.281

27 December 2018

Acenocoumarol (English)

quotation

CAS no.: 152-72-7 (English)

1 reference

World Health Organisation international non-proprietary name numeric ID

Acenocoumarol (English)

publication date

17 November 2015

503

1 reference

reference URL

https://mednet-communities.net/inn/db/ViewINN.aspx?i=503

Guide to Pharmacology Ligand ID

9015

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

9015

D03.383.663.283.446.520.079

acenocoumarol (English)

19 November 2016

Acenocoumarol

0 references

MeSH tree code

broader concept

4-Hydroxycoumarins

0 references

D03.633.100.150.446.520.079

0 references

1 reference

acenocoumarol (English)

19 November 2016

DrugBank ID

DB01418

1 reference

Human Metabolome Database ID

HMDB0015487

2 references

based on heuristic

inferred from InChIKey

2 references

acenocoumarol (English)

19 November 2016

0 references

1 reference

1 reference